COMP <GO>
TMDX vs AXGN // EV/EBITDA & P/E VALUATION
TransMedics Group Inc. (NASDAQ) VS. Axogen Inc. (NASDAQ) • 15-METRIC TALLY: TMDX 7
— AXGN 4
■ METRIC PARITY
LAST: $65.99 (-1.68%) • MKT CAP: $2.33B
valuation
14.6x
LAST: $49.37 (-0.52%) • MKT CAP: $2.96B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TMDX VS. AXGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TMDX | AXGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.90% | 74.30% | -14.40 | AXGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.10% | -2.60% | +20.70 | TMDX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 14.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 5.74% | -0.10% | +5.84 | TMDX | /fcf-yield <GO> |
| Operating Margin | 17.90% | -3.50% | +21.40 | TMDX | /operating-margins <GO> |
| Net Profit Margin | 31.40% | -7.00% | +38.40 | TMDX | /net-margins <GO> |
| Revenue Growth (YoY) | 37.10% | 20.20% | +16.90 | TMDX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.50 | 18.64 | -15.14 | AXGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | TMDX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.5 | 74.3 | -41.80 | AXGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.10 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.2x | 18.0x | -7.80 | TMDX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.33B | $2.96B | -$637.0M | AXGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TMDX REV | AXGN REV | TMDX GROSS % | AXGN GROSS % | TMDX FCF | AXGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $605.5M | $225.2M | 59.9% | 74.3% | $133.6M | -$2.9M |
| FY 2024 | $441.5M | $187.3M | 59.4% | 75.8% | -$80.9M | $1.4M |
| FY 2023 | $241.6M | $159.0M | — | — | -$13.0M | -$12.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TMDX // BETA —
AXGN // BETA 1.10